Publikationen 2010:

Halimeh S:
"Menorrhagie beim von Willebrand-Syndrom: ein wichtiges Symptom in der klinischen Diagnostik."
Frauenarzt 2010 (51): 1028-32.

S. Halimeh:
"Wenn aus Tagen Wochen werden: Von der Monatsblutung zur Diagnose von Willebrand-Syndrom".
Hämostaseologie 2010;3:169-79

Alesci S, Halimeh S, Kadar J, et al.
"Latest interim results from a German prospective post-marketing surveillance of treatment of von Willebrand disease with a new generation VWF/FVIII concentrate." 
Haemophilia. 2010;16(2010):8216-8216.

Halimeh S, Krümpel A, Rott H, et al.
"Long-term prophylactic treatment of juvenile von Willebrand type 2 and 3 patients with two different von Willebrand factor concentrates a two-center cohort study." 
Haemophilia. 2010;16(2010):8216-8216.

Halimeh S, Faeser B, Budde U, Laws H, Rott H.
"Treatment of a patient with type 3 von Willebrand disease and alloantibody against von Willebrand factor." 
Haemophilia. 2007;16(2010):8216-8216.

Peyvandi F, Menegatti M, Palla R, Halimeh S. et al.
"The European Network of Rare Bleeding Disorders (EN-RBD) project: results of 3-years analysis." 
Haemophilia. 2010;16:8216-8216.

Halimeh S, Kenet G, Bidlingmaier C, et al.
"Validation of a predictive model for identifying an increased risk for clinical meaningful inhibitor developement in children with hemophilia A - results of a multicenter cohort study." 
Haemophilia. 2010;16:8216-8216."

Rott H:
"Behandlung von Wechseljahrsbeschwerden unter Einnahme von Vitamin-K-Antagonisten."
Die Gerinnung. 2010;40:3-6

Iorio a, Halimeh S, Holzhauer S, et al.
"Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma-derived or recombinant factor VIII concentrates: a systematic review." 
Journal of thrombosis and haemostasis : JTH. 2010;8(6):1256-65.

Halimeh S, Junker R, Thedick S, et al.
"Developmental hemostasis: Impact of different coagulation test systems on pediatric reference values." 
54. Jahrestagung der Ges. für Thrombose-und Hämostaseforschung Februar 2010, Nürnberg. 2010:Poster 17-12.

Faeser B, Stoll H.
"Study group: medical technicians in Haemostaseology." 
54. Jahrestagung der Ges. für Thrombose-und Hämostaseforschung Februar 2010, Nürnberg. 2010:Poster 19-03.

Rott H, Halimeh S.:
"von Willebrand´s disease is the most common cause for hypermenorrhagia in women at younger age." 
54. Jahrestagung der Ges. für Thrombose-und Hämostaseforschung Februar 2010, Nürnberg. 2010:Poster 07-20.

Ivaskevicius V, Biswas A, Ohlenforst S, Rott H. et al.
"Mutations affecting disulphide bonds contribute to a fairly common prevalence F13B gene defects: results of a genetic study in 13 families with heterozygous Factor XIII subunit B deficiency." 
54. Jahrestagung der Ges. für Thrombose-und Hämostaseforschung Februar 2010, Nürnberg. 2010:Poster 06-09.

Halimeh S, Rott H.:
"Factor VII activity in pregnant women with mild factor VII deficiency on recombinant factor VIIa versus no substitution therapy." 
54. Jahrestagung der Ges. für Thrombose-und Hämostaseforschung Februar 2010, Nürnberg. 2010:Poster 15-08.

Halimeh S, Rott H, Bicker M, et al.
"Acquired von Willebrand disease with underlying haematologic malignancy."
54. Jahrestagung der Ges. für Thrombose-und Hämostaseforschung Februar 2010, Nürnberg. 2010:Poster 05-14.

Halimeh S, Angelis GD, Sander a, et al.:
"Multiplate whole blood impedance point of care aggregometry: preliminary reference values in healthy infants, children and adolescents." 
Klinische Pädiatrie. 2010;222(3):158-63. 

Kawamura R, Pope LH, Christensen MO, et al.
"Mitotic chromosomes are constrained by topoisomerase II–sensitive DNA entanglements." 
Clinical Chemistry. 2010.